Clinical trial
Pilot Study on Efficacy and Safety of a Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults. ANRS 091 MONTANA
NCT00196599 is registered in ClinicalTrials.gov with ANRS, Emerging Infectious Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study on Efficacy and Safety of a Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults. ANRS 091 MONTANA
- Lead sponsor
- ANRS, Emerging Infectious Diseases
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 1999
- Completion date
- September 30, 2004
- Enrollment
- 39
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
antiretroviral naive, hiv infections